178 related articles for article (PubMed ID: 25541837)
1. [Anti-platelet therapy in patients with acute coronary syndromes].
Kopaleishvili LA; Dzhashi IM
Georgian Med News; 2014 Nov; (236):105-10. PubMed ID: 25541837
[TBL] [Abstract][Full Text] [Related]
2. Platelet function in ischemic heart disease.
Picker SM
J Cardiovasc Pharmacol; 2013 Feb; 61(2):166-74. PubMed ID: 23107874
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy and vascular disease: an update.
Buch MH; Prendergast BD; Storey RF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
[TBL] [Abstract][Full Text] [Related]
4. The role of platelets in athero-thrombotic events.
Freynhofer MK; Bruno V; Wojta J; Huber K
Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
[TBL] [Abstract][Full Text] [Related]
5. Platelet turnover in atherothrombotic disease.
Lordkipanidzé M
Curr Pharm Des; 2012; 18(33):5328-43. PubMed ID: 22724418
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in patients with acute coronary syndromes: how to make the right choice?
Eitan A; Nikolsky E
Minerva Med; 2013 Aug; 104(4):357-81. PubMed ID: 24008600
[TBL] [Abstract][Full Text] [Related]
7. Platelet interactions as therapeutic targets for prevention of atherothrombosis.
Smid J; Braun-Dullaeus R; Gawaz M; Langer HF
Future Cardiol; 2009 May; 5(3):285-96. PubMed ID: 19450054
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
Arazi HC; Badimon JJ
Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
[TBL] [Abstract][Full Text] [Related]
9. Update on the efficacy of statin treatment in acute coronary syndromes.
Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 expression and activation in acute coronary syndrome patients on dual anti-platelet therapy.
Hally KE; La Flamme AC; Larsen PD; Harding SA
Thromb Res; 2016 Dec; 148():89-95. PubMed ID: 27815972
[TBL] [Abstract][Full Text] [Related]
11. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis.
Muruganantham S; Krishnaswami V; Alagarsamy S; Kandasamy R
Curr Drug Targets; 2021; 22(4):399-419. PubMed ID: 33109044
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
13. Platelet pathophysiology, pharmacology, and function in coronary artery disease.
Ibrahim H; Kleiman NS
Coron Artery Dis; 2017 Nov; 28(7):614-623. PubMed ID: 28644213
[TBL] [Abstract][Full Text] [Related]
14. Update on acute coronary syndromes: the pathologists' view.
Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
[TBL] [Abstract][Full Text] [Related]
15. New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.
Sinhal AR; Aylward PE
Clin Ther; 2013 Aug; 35(8):1064-8. PubMed ID: 23973039
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
[TBL] [Abstract][Full Text] [Related]
17. Novel antiplatelet therapy.
Gaglia MA; Manoukian SV; Waksman R
Am Heart J; 2010 Oct; 160(4):595-604. PubMed ID: 20934552
[TBL] [Abstract][Full Text] [Related]
18. Recent therapeutic approaches to platelet activation in coronary artery disease.
Tousoulis D; Paroutoglou IP; Papageorgiou N; Charakida M; Stefanadis C
Pharmacol Ther; 2010 Aug; 127(2):108-20. PubMed ID: 20546778
[TBL] [Abstract][Full Text] [Related]
19. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?
Matusik P; Guzik B; Weber C; Guzik TJ
Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
Takenaka K; Yamagishi S; Matsui T; Nakamura K; Jinnouchi Y; Yoshida Y; Ueda S; Katsuki Y; Katsuda Y; Imaizumi T
Atherosclerosis; 2008 Mar; 197(1):25-33. PubMed ID: 17850801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
